title: Management of malignant pleural effusion.
abstract: Malignant pleural effusion (MPE) often presents in patients with cancer at an advanced stage and thus carries a poor prognosis. This review updates the current knowledge on the management of MPE, focusing on recent literature about the efficacy and safety of the most common methods, including pleurodesis by either thoracoscopy with talc insufflation or thoracostomy with talc slurry, use of an indwelling pleural catheter, and intrapleural chemotherapy. Talc remains the agent of choice in pleurodesis, although the use of alternative agents continues to be explored. The choice of procedure to achieve pleurodesis depends on careful patient selection based on predictive factors and individual characteristics. Talc pleuro-desis is relatively well tolerated and safe, as is an indwelling pleural catheter, in an appropriate patient population. Because MPE is a common problem in cancer patients, future research with more randomized, prospective designs and innovative interventions is needed.
authors.affiliation: Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Bunting/Blaustein Cancer Research Building, 1650 Orleans Street, Baltimore, MD 21231, USA.
authors.forename: Hongbin
authors.initials: H
authors.lastname: Chen
authors.forename: Julie
authors.initials: J
authors.lastname: Brahmer
mesh_terms: D051520:Antiperspirants / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care; D016066:Pleural Effusion, Malignant / Q000188:drug therapy* / Q000209:etiology; D018700:Pleurodesis; D013627:Talc / Q000627:therapeutic use*
chemical_list: D051520:Antiperspirants; D013627:Talc
references.citation: J Thorac Oncol. 2007 Aug;2(8):706-14
references.pmid: 17762336
references.citation: Chest. 2006 Feb;129(2):362-368
references.pmid: 16478853
references.citation: Chest. 2005 Sep;128(3):1431-5
references.pmid: 16162739
references.citation: Lancet. 2007 May 5;369(9572):1494-1496
references.pmid: 17482965
references.citation: Chest. 2007 Apr;131(4):1232-4
references.pmid: 17426232
references.citation: J Thorac Oncol. 2007 Aug;2(8):686-93
references.pmid: 17762334
references.citation: J Pain Symptom Manage. 2005 Jul;30(1):75-9
references.pmid: 16043010
references.citation: Chest. 2007 Nov;132(5):1584-90
references.pmid: 17890482
references.citation: Ann Surg Oncol. 2007 Oct;14(10):2700-1
references.pmid: 17151792
references.citation: Eur J Cardiothorac Surg. 2005 Nov;28(5):750-3
references.pmid: 16198593
references.citation: Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001
references.pmid: 11069845
references.citation: Chest. 2007 Sep;132(3):1036-41
references.pmid: 17873197
references.citation: Ann Surg Oncol. 2007 Oct;14(10):2698-9
references.pmid: 17657544
references.citation: Eur J Cardiothorac Surg. 2006 May;29(5):829-38
references.pmid: 16626967
references.citation: Lung Cancer. 2005 Oct;50(1):123-7
references.pmid: 15998551
references.citation: Chest. 2005 Mar;127(3):909-15
references.pmid: 15764775
references.citation: Eur J Cardiothorac Surg. 2005 Jan;27(1):19-22
references.pmid: 15621465
references.citation: Lancet. 2007 May 5;369(9572):1535-1539
references.pmid: 17482984
references.citation: Clin Cancer Res. 2005 Oct 15;11(20):7444-53
references.pmid: 16243818
references.citation: Ann Oncol. 2006 Dec;17(12):1853
references.pmid: 16790519
references.citation: Lung Cancer. 2006 Oct;54(1):51-5
references.pmid: 16920219
references.citation: Chest. 2006 Feb;129(2):356-361
references.pmid: 16478852
references.citation: Br J Cancer. 2006 Sep 18;95(6):717-21
references.pmid: 16940982
references.citation: Eur Respir J. 2005 Apr;25(4):600-4
references.pmid: 15802331
references.citation: Eur J Cardiothorac Surg. 2008 Jan;33(1):89-94
references.pmid: 17983758
references.citation: Eur J Cardiothorac Surg. 2006 Dec;30(6):827-32
references.pmid: 17113008